Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, Dormishian F, Domingo R Jr, Ellis MC, Fullan A, Hinton LM, Jones NL, Kimmel BE, Kronmal GS, Lauer P, Lee VK, Loeb DB, Mapa FA, McClelland E, Meyer NC, Mintier GA, Moeller N, Moore T, Morikang E, Wolff RK, et al. (1996) A novel MHC class I-like gene is mutated in patients with hereditary hemochromatosis. Nature Genetics Aug;13(4):399-408.

Feder JN, Penny DM, Irrinki A, Lee VK, Lebron JA, Watson N, Tsuchihashi Z, Sigal E, Bjorkman PJ, Schatzman RC. (1998) The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc Natl Acad Sci U S A Feb 17;95(4):1472

Lebron JA, Bennett MJ, Vaughn DE, Chirino AJ, Snow PM, Mintier GA, Feder JN, Bjorkman PJ. (1998) Crystal structure of the hemochromatosis protein HFE and characterization of its interaction with transferrin receptor. Cell Apr 3;93(1):111-23

Carella M, D'Ambrosio L, Totaro A, Grifa A, Valentino MA, Piperno A, Girelli D, Roetto A, Franco B, Gasparini P, Camaschella C. (1997) Mutation analysis of the HLA-H gene in Italian hemochromatosis patients. Am J Hum Genet  Apr;60(4):828-32

Roberts AG, Whatley SD, Morgan RR, Worwood M, Elder GH. (1997) Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda. Lancet  Feb 1;349(9048):321-3

Organizations

American Hemochromatosis Society - official page.

Use of Blood Therapeutically Drawn from Hemochromatosis Patients - a Council on Scientific Affairs Report .

The Canadian Hemochromatosis Society - Member of the International Association of Haemochromatosis Societies. Founded by Marie Warder 1982.

Why patients with hemochromatosis needing therapeutic phlebotomy should not become blood donors - from American Red Cross.